December 21, 2017 / 1:40 PM / 6 months ago

BRIEF-Jazz Pharma Submits New Drug Application For Solriamfetol (JZP-110)

Dec 21 (Reuters) - Jazz Pharmaceuticals Plc:

* JAZZ PHARMACEUTICALS SUBMITS NEW DRUG APPLICATION FOR SOLRIAMFETOL (JZP-110) FOR EXCESSIVE SLEEPINESS ASSOCIATED WITH NARCOLEPSY AND OBSTRUCTIVE SLEEP APNEA

* JAZZ PHARMACEUTICALS PLC - SUBMISSION OF NDA TO U.S. FDA SEEKING MARKETING APPROVAL FOR SOLRIAMFETOL Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below